Ovid Therapeutics Inc.股价飙升11.65% 市值涨182.33万美元

市场透视03-10

北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.（OVID.us）股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。最近的财报数据显示，该股实现营业收入173000.00美元，净利润-14.01百万美元，每股收益-0.20美元，毛利4000.00美元，市盈率-1.18倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2518275516?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-10 21:33","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2518275516","market":"us","top_or_hot":-1,"title":"Ovid Therapeutics Inc.股价飙升11.65% 市值涨182.33万美元","media":"市场透视","content":"<div>\n<p>北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.（OVID.us）股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。最近的财报数据显示，该股实现营业收入173000.00美元，净利润-14.01百万美元，每股收益-0.20美元，毛利4000.00美元，市盈率-1.18倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ovid Therapeutics Inc.股价飙升11.65% 市值涨182.33万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOvid Therapeutics Inc.股价飙升11.65% 市值涨182.33万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-10 21:33 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.（OVID.us）股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。最近的财报数据显示，该股实现营业收入173000.00美元，净利润-14.01百万美元，每股收益-0.20美元，毛利4000.00美元，市盈率-1.18倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OVID","symbol_name":"Ovid Therapeutics Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b","article_id":"2518275516","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213325a26a2559&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2518275516","pubTimestamp":1741613604,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"OVID":"Ovid Therapeutics Inc.","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Ovid Therapeutics Inc. Stock Soars 11.65%, Market Cap Ups $1.8233 Million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":0.6,"OVID":0.6},"content_text":"北京时间2025年03月10日21时33分，Ovid Therapeutics Inc.（OVID.us）股票出现波动，股价急速上涨11.65%。截至发稿，该股报0.580美元/股，成交量2.52万股，换手率0.04%，振幅3.91%。最近的财报数据显示，该股实现营业收入173000.00美元，净利润-14.01百万美元，每股收益-0.20美元，毛利4000.00美元，市盈率-1.18倍。机构评级方面，在所有9家参与评级的机构中，89%的券商给予买入建议，11%的券商给予持有建议，无券商给予卖出建议。Ovid Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2080.34%、404.77%、61.86%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为100.05%、99.13%、98.72%。Ovid Therapeutics Inc.公司简介：Ovid Therapeutics Inc 是一家生物制药公司，致力于减少癫痫发作并切实改善罕见癫痫和癫痫相关神经系统疾病患者的生活。 该公司已经建立了差异化的药物管线，具有治疗癫痫发作的潜在一流药物作用机制。 该管线已经产生了两个具有潜在一流作用机制的癫痫项目，以及一个具有潜在一流作用机制的癫痫项目。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2518275516","isCrawlerRequest":true}